# Heritage Global Inc.: financial statements, quarterly

HGBL · Nasdaq · CIK 849145 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hgbl.md) · [Financials](/companies/hgbl/financials.md) · [Filings](/companies/hgbl/filings.md) · [Insiders](/companies/hgbl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hgbl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.6](/filings/0000950170-24-123236.md) | [15.3 d](/filings/0000950170-25-038691.md) | [12.2](/filings/0000950170-25-066888.md) | [12.0](/filings/0000950170-25-104951.md) | [10.4](/filings/0001193125-25-269427.md) | [10.8 d](/filings/0001193125-26-104062.md) | [13.5](/filings/0001193125-26-211813.md) | [14.3](/filings/0001193125-26-349109.md) | [11.4](/filings/0001193125-25-269427.md) | [11.9 d](/filings/0001193125-26-104062.md) | [12.7](/filings/0001193125-26-211813.md) | [12.3](/filings/0001193125-26-349109.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [12.0 d](/filings/0001193125-25-269427.md) | [11.0 d](/filings/0001193125-26-104062.md) | [49.0](/filings/0001193125-26-211813.md) | [6.0 d](/filings/0001193125-26-349109.md) |
| Selling, general and administrative | $m | [6.8](/filings/0000950170-24-123236.md) | [6.5 d](/filings/0000950170-25-038691.md) | [6.4](/filings/0000950170-25-066888.md) | [6.3](/filings/0000950170-25-104951.md) | [5.7](/filings/0001193125-25-269427.md) | [5.9 d](/filings/0001193125-26-104062.md) | [6.5](/filings/0001193125-26-211813.md) | [6.1](/filings/0001193125-26-349109.md) | [6.0](/filings/0001193125-25-269427.md) | [6.3 d](/filings/0001193125-26-104062.md) | [7.6](/filings/0001193125-26-211813.md) | [10.8](/filings/0001193125-26-349109.md) |
| Operating income | $m | [2.8](/filings/0000950170-24-123236.md) | [4.6 d](/filings/0000950170-25-038691.md) | [2.6](/filings/0000950170-25-066888.md) | [3.5](/filings/0000950170-25-104951.md) | [1.5](/filings/0001193125-25-269427.md) | [1.5 d](/filings/0001193125-26-104062.md) | [1.4](/filings/0001193125-26-211813.md) | [2.2](/filings/0001193125-26-349109.md) | [1.3](/filings/0001193125-25-269427.md) | [0.8 d](/filings/0001193125-26-104062.md) | [1.0](/filings/0001193125-26-211813.md) | [(20.9)](/filings/0001193125-26-349109.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.7](/filings/0000950170-24-123236.md) | [(0.4) d](/filings/0000950170-25-038691.md) | [0.7](/filings/0000950170-25-066888.md) | [0.9](/filings/0000950170-25-104951.md) | [0.4](/filings/0001193125-25-269427.md) | [1.8 d](/filings/0001193125-26-104062.md) | [0.4](/filings/0001193125-26-211813.md) | [0.6](/filings/0001193125-26-349109.md) | [(0.8)](/filings/0001193125-25-269427.md) | [0.5 d](/filings/0001193125-26-104062.md) | [0.3](/filings/0001193125-26-211813.md) | [(5.1)](/filings/0001193125-26-349109.md) |
| Net income | $m | [2.0](/filings/0000950170-24-123236.md) | [4.9 d](/filings/0000950170-25-038691.md) | [1.8](/filings/0001193125-25-269427.md) | [2.5](/filings/0001193125-25-269427.md) | [1.1](/filings/0001193125-25-269427.md) | [(0.2) d](/filings/0001193125-26-104062.md) | [1.1](/filings/0001193125-26-349109.md) | [1.6](/filings/0001193125-26-349109.md) | [0.6](/filings/0001193125-25-269427.md) | [0.3 d](/filings/0001193125-26-104062.md) | [0.7](/filings/0001193125-26-349109.md) | [(15.9)](/filings/0001193125-26-349109.md) |
| Diluted EPS | $ per share | [0.05](/filings/0000950170-24-123236.md) | not reported | [0.05](/filings/0000950170-25-066888.md) | [0.07](/filings/0000950170-25-104951.md) | [0.03](/filings/0001193125-25-269427.md) | not reported | [0.03](/filings/0001193125-26-211813.md) | [0.05](/filings/0001193125-26-349109.md) | [0.02](/filings/0001193125-25-269427.md) | not reported | [0.02](/filings/0001193125-26-211813.md) | [(0.46)](/filings/0001193125-26-349109.md) |
| Basic EPS | $ per share | [0.05](/filings/0000950170-24-123236.md) | not reported | [0.05](/filings/0000950170-25-066888.md) | [0.07](/filings/0000950170-25-104951.md) | [0.03](/filings/0001193125-25-269427.md) | not reported | [0.03](/filings/0001193125-26-211813.md) | [0.05](/filings/0001193125-26-349109.md) | [0.02](/filings/0001193125-25-269427.md) | not reported | [0.02](/filings/0001193125-26-211813.md) | [(0.46)](/filings/0001193125-26-349109.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [15.6](/filings/0000950170-23-061977.md) | [12.3](/filings/0000950170-25-038691.md) | [15.6](/filings/0000950170-24-056832.md) | [24.6](/filings/0000950170-24-093848.md) | [26.6](/filings/0000950170-24-123236.md) | [21.7](/filings/0001193125-26-104062.md) | [18.8](/filings/0000950170-25-066888.md) | [19.8](/filings/0000950170-25-104951.md) | [19.4](/filings/0001193125-25-269427.md) | [20.5](/filings/0001193125-26-349109.md) | [11.6](/filings/0001193125-26-211813.md) | [13.2](/filings/0001193125-26-349109.md) |
| Current assets | $m | [33.9](/filings/0000950170-23-061977.md) | [26.3](/filings/0000950170-25-038691.md) | [28.9](/filings/0000950170-24-056832.md) | [35.9](/filings/0000950170-24-093848.md) | [37.0](/filings/0000950170-24-123236.md) | [33.1](/filings/0001193125-26-104062.md) | [29.5](/filings/0000950170-25-066888.md) | [32.1](/filings/0000950170-25-104951.md) | [31.8](/filings/0001193125-25-269427.md) | [33.6](/filings/0001193125-26-349109.md) | [23.8](/filings/0001193125-26-211813.md) | [23.0](/filings/0001193125-26-349109.md) |
| Total assets | $m | [84.4](/filings/0000950170-23-061977.md) | [83.2](/filings/0000950170-25-038691.md) | [83.7](/filings/0000950170-24-056832.md) | [90.0](/filings/0000950170-24-093848.md) | [88.5](/filings/0000950170-24-123236.md) | [81.3](/filings/0001193125-26-104062.md) | [86.7](/filings/0000950170-25-066888.md) | [87.7](/filings/0000950170-25-104951.md) | [86.5](/filings/0001193125-25-269427.md) | [88.4](/filings/0001193125-26-349109.md) | [85.0](/filings/0001193125-26-211813.md) | [70.4](/filings/0001193125-26-349109.md) |
| Current liabilities | $m | [20.1](/filings/0000950170-23-061977.md) | [14.7](/filings/0000950170-25-038691.md) | [13.9](/filings/0000950170-24-056832.md) | [18.0](/filings/0000950170-24-093848.md) | [20.7](/filings/0000950170-24-123236.md) | [14.6](/filings/0001193125-26-104062.md) | [14.8](/filings/0000950170-25-066888.md) | [15.7](/filings/0000950170-25-104951.md) | [13.9](/filings/0001193125-25-269427.md) | [15.5](/filings/0001193125-26-349109.md) | [12.2](/filings/0001193125-26-211813.md) | [13.6](/filings/0001193125-26-349109.md) |
| Total liabilities | $m | [28.0](/filings/0000950170-23-061977.md) | [22.1](/filings/0000950170-25-038691.md) | [20.7](/filings/0000950170-24-056832.md) | [24.2](/filings/0000950170-24-093848.md) | [22.4](/filings/0000950170-24-123236.md) | [16.1](/filings/0001193125-26-104062.md) | [21.3](/filings/0000950170-25-066888.md) | [22.0](/filings/0000950170-25-104951.md) | [20.0](/filings/0001193125-25-269427.md) | [21.5](/filings/0001193125-26-349109.md) | [17.2](/filings/0001193125-26-211813.md) | [18.5](/filings/0001193125-26-349109.md) |
| Long-term debt | $m | not reported | [7.2](/filings/0000950170-24-031436.md) | not reported | not reported | not reported | not reported | [4.4](/filings/0000950170-25-066888.md) | [4.2](/filings/0000950170-25-104951.md) | [4.1](/filings/0001193125-25-269427.md) | not reported | [4.1](/filings/0001193125-26-211813.md) | [4.1](/filings/0001193125-26-349109.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [56.4](/filings/0000950170-24-123236.md) | [61.1](/filings/0001193125-26-104062.md) | [63.0](/filings/0001193125-25-269427.md) | [65.8](/filings/0001193125-25-269427.md) | [66.1](/filings/0001193125-25-269427.md) | [65.2](/filings/0001193125-26-349109.md) | [65.4](/filings/0001193125-26-349109.md) | [65.7](/filings/0001193125-26-349109.md) | [66.5](/filings/0001193125-25-269427.md) | [67.0](/filings/0001193125-26-349109.md) | [67.8](/filings/0001193125-26-349109.md) | [51.9](/filings/0001193125-26-349109.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [5,912 d](/filings/0000950170-24-123236.md) | [446 d](/filings/0000950170-25-038691.md) | [1,676](/filings/0000950170-25-066888.md) | [6,054 d](/filings/0000950170-25-104951.md) | [5,524 d](/filings/0001193125-25-269427.md) | [(5,509) d](/filings/0001193125-26-104062.md) | [2,617](/filings/0001193125-26-211813.md) | [1,879 d](/filings/0001193125-26-349109.md) | [61.0 d](/filings/0001193125-25-269427.md) | [1,580 d](/filings/0001193125-26-104062.md) | [(2,679)](/filings/0001193125-26-211813.md) | [1,617 d](/filings/0001193125-26-349109.md) |
| Capital expenditure | $k | [17.0 d](/filings/0000950170-24-123236.md) | [20.0 d](/filings/0000950170-25-038691.md) | [22.0](/filings/0000950170-25-066888.md) | [77.0 d](/filings/0000950170-25-104951.md) | [35.0 d](/filings/0001193125-25-269427.md) | [3.0 d](/filings/0001193125-26-104062.md) | [7,408](/filings/0001193125-26-211813.md) | [159 d](/filings/0001193125-26-349109.md) | [294 d](/filings/0001193125-25-269427.md) | [609 d](/filings/0001193125-26-104062.md) | [562](/filings/0001193125-26-211813.md) | [209 d](/filings/0001193125-26-349109.md) |
| Share repurchases | $k | [0.0 d](/filings/0000950170-24-123236.md) | [400 d](/filings/0000950170-25-038691.md) | [0.0](/filings/0000950170-25-066888.md) | [0.0 d](/filings/0000950170-25-104951.md) | [1,058 d](/filings/0001193125-25-269427.md) | [1,140 d](/filings/0001193125-26-104062.md) | [1,042](/filings/0001193125-26-211813.md) | [1,585 d](/filings/0001193125-26-349109.md) | [0.0 d](/filings/0001193125-25-269427.md) | [0.0 d](/filings/0001193125-26-104062.md) | [141](/filings/0001193125-26-211813.md) | [134 d](/filings/0001193125-26-349109.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.2](/filings/0000950170-23-061977.md) | [37.3](/filings/0000950170-24-056832.md) | [37.7](/filings/0000950170-24-093848.md) | [37.6](/filings/0000950170-24-123236.md) | [37.4](/filings/0000950170-25-066888.md) | [36.8](/filings/0000950170-25-104951.md) | [37.2](/filings/0001193125-25-269427.md) | [36.1](/filings/0001193125-26-211813.md) | [35.5](/filings/0001193125-26-349109.md) | [35.2](/filings/0001193125-25-269427.md) | [35.0](/filings/0001193125-26-211813.md) | [34.6](/filings/0001193125-26-349109.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,639,445 at 2026-08-01, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-349109.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.